![Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11912-023-01447-9/MediaObjects/11912_2023_1447_Fig1_HTML.png)
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports
![Filippo MAFFEZZONI | Medical Doctor | Doctor of Medicine | Azienda Ospedaliera di Desenzano del Garda, Desenzano del Garda | AOD | Department of Internal Medicine | Research profile Filippo MAFFEZZONI | Medical Doctor | Doctor of Medicine | Azienda Ospedaliera di Desenzano del Garda, Desenzano del Garda | AOD | Department of Internal Medicine | Research profile](https://i1.rgstatic.net/ii/profile.image/1012443249659905-1618396689127_Q512/Filippo-Maffezzoni.jpg)
Filippo MAFFEZZONI | Medical Doctor | Doctor of Medicine | Azienda Ospedaliera di Desenzano del Garda, Desenzano del Garda | AOD | Department of Internal Medicine | Research profile
![Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11912-023-01447-9/MediaObjects/11912_2023_1447_Fig2_HTML.png)
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients | Current Oncology Reports
![Antonella TURLA | Medical Doctor | Medical Doctor | Università degli Studi di Brescia, Brescia | UNIBS | Medical Oncology | Research profile Antonella TURLA | Medical Doctor | Medical Doctor | Università degli Studi di Brescia, Brescia | UNIBS | Medical Oncology | Research profile](https://www.researchgate.net/publication/373832508/figure/tbl3/AS:11431281188138138@1694525753475/Treatment-activity-in-the-two-groups_Q320.jpg)
Antonella TURLA | Medical Doctor | Medical Doctor | Università degli Studi di Brescia, Brescia | UNIBS | Medical Oncology | Research profile
![Marco BERGAMINI | Medical Doctor | Doctor of Medicine | Università degli Studi di Brescia, Brescia | UNIBS | Department of Medical and Surgical Specialties, Radiological Sciences and Public Health | Research profile Marco BERGAMINI | Medical Doctor | Doctor of Medicine | Università degli Studi di Brescia, Brescia | UNIBS | Department of Medical and Surgical Specialties, Radiological Sciences and Public Health | Research profile](https://www.researchgate.net/publication/375117433/figure/fig1/AS:11431281202306723@1698800161197/figure-fig1_Q320.jpg)
Marco BERGAMINI | Medical Doctor | Doctor of Medicine | Università degli Studi di Brescia, Brescia | UNIBS | Department of Medical and Surgical Specialties, Radiological Sciences and Public Health | Research profile
![Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis in: Endocrine-Related Cancer Volume 28 Issue 8 (2021) Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis in: Endocrine-Related Cancer Volume 28 Issue 8 (2021)](https://erc.bioscientifica.com/view/journals/erc/28/8/images/ERC-21-0123fig3.jpeg)